Nyaradzo Mavis Mgodi, (MBChB, MMed) – JIAS Deputy Editor, Associate Editor at Frontiers in Global Reproductive Health – HIV and STIs – is a clinical pathologist with over 10 years of experience conducting clinical trials for HIV prevention in women of reproductive age in Sub-Saharan Africa, including Zimbabwe, home to the University of Zimbabwe-Clinical Trials Research Centre. As lead investigator in Harare, she has overseen the implementation of several trials assessing acceptability, safety and effectiveness of oral PrEP, vaginal microbicides, the Dapivirine vaginal ring, long-acting injectable PrEP and broadly neutralizing antibodies for HIV prevention in African women at risk for HIV. She is protocol co-chairperson for HVTN 703/HPTN 081 study, also known as Antibody Mediated Prevention (AMP) and of MTN 025/HOPE study. Nyaradzo, who serves as the International Principal Investigator on the HPTN Executive Committee, is also a scientific reviewer for the Medical Research Council of Zimbabwe, and has served as a technical advisor for the Zimbabwe Population-based HIV Impact Assessment (ZIMPHIA) survey. She is a member of the Policy and Implementation Steering Committee for the Global Evaluation of Microbicide Sensitivity (GEMS) project, HIVR4P Program Organizing Committee and served as Conference Advisory Committee member for International AIDS Society (IAS) 2017.